Pharma Mar SA
Pharma Mar's GHG Emissions Data Preview
In 2023, Pharma Mar completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Pharma Mar has also provided a category-level breakdown for 3 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
a
a
aCreate your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Verified Sources Behind Pharma Mar’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Pharma Mar’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Insights into Pharma Mar's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Pharma Mar amounted to 3,083 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Pharma Mar increased by 21.95%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Pharma Mar's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Pharma Mar's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Pharma Mar were 1,233 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2022), Pharma Mar's Scope 1 emissions increased by 6.57%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Pharma Mar's Scope 2 emissions?
In 2023, Pharma Mar reported Scope 2 greenhouse gas (GHG) emissions of 1,850 tCO₂e using the market-based method. a
Has Pharma Mar reduced its Scope 2 emissions over time?
Compared to the previous year (2022), Pharma Mar's Scope 2 emissions (Market-Based) rose by 34.94% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does Pharma Mar use for Scope 2 reporting?
In 2023, Pharma Mar reported its Scope 2 emissions using the market-based method. a
Pharma Mar's Scope 2 Emissions Over Time
- Total Scope 2 Market-Based
Insights into Pharma Mar's Value Chain Emissions
In 2023, Pharma Mar reported 11,066 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2023 disclosure of Pharma Mar includes a breakdown across 3 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2022, reflecting improved emissions accounting practices and greater transparency across the company's value chain a
Pharma Mar's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Pharma Mar's Scope 3 emissions?
In 2023, Pharma Mar reported total Scope 3 emissions of 11,066 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 0% of these emissions originated from upstream activities such as purchased goods and capital goods, while 100% came from downstream activities like product use, distribution, and end-of-life treatment. a
Compared to the previous year (2022), Pharma Mar's Scope 3 emissions increased by 91.95%, suggesting that the company faced challenges in reducing emissions across its value chain. a
What categories of Scope 3 emissions does Pharma Mar disclose?
In 2023, Pharma Mar reported emissions for 3 out of the 15 Scope 3 categories defined by the GHG Protocol. a
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
What are the main sources of Pharma Mar's Scope 3 emissions?
In 2023, the largest contributors to Pharma Mar's Scope 3 emissions were: a
- Investments (Cat. 15): 7,438 tCO₂e (81.86%)
- Other/Unspecified Sources: 1,361 tCO₂e (14.98%)
- Use of Sold Products (Cat. 11): 287 tCO₂e (3.16%)
Pharma Mar's Scope 3 Emissions by Categories
Insights into Pharma Mar’s GHG Emissions Intensity Compared to Industry Peers
In 2023, Pharma Mar reported Scope 1 greenhouse gas (GHG) emissions of 1,233 tCO₂e and total revenues of USD 175 millions. This translates into an emissions intensity of 7.04 tCO₂e per millions USD. a
Pharma Mar's Scope 1 Emissions Intensity Compared to Peers
How does Pharma Mar's GHG emissions intensity compare to its peers?
In 2023, Pharma Mar reported a Scope 1 emissions intensity of 7.04 tCO₂e per millions USD. Compared to the peer group median of 3.76, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Pharma Mar rank on GHG emissions intensity within its industry?
In 2023, Pharma Mar ranked 16 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Pharma Mar is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
Insights into Pharma Mar's Total Carbon Footprint
In 2023, Pharma Mar reported a total carbon footprint of 14,149 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 70.61% increase compared to 2022, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Pharma Mar's total carbon footprint was Scope 3 emissions, accounting for 78.21% of the company's total carbon footprint, followed by Scope 2 emissions at 13.08%. a